A new vaccination campaign targeting 15-year-olds against meningitis B is being considered following recent outbreaks, with health officials recommending catch-up programs. Tragic incidents in Kent claimed the lives of two teenagers earlier this year, prompting the Joint Committee on Vaccination and Immunisation (JCVI) to propose an expanded vaccination initiative after a previous drive for university students. The government is now reviewing this suggestion.

Prof Wei Shen Lim, chair of the JCVI, emphasized the severity of invasive meningococcal disease and its potentially devastating consequences, underscoring the importance of preventive measures. The JCVI has collaborated with meningitis charities, acknowledging the valuable input from individuals affected by the disease.

The JCVI highlights the risks associated with Meningococcal B, which can lead to severe health complications, including brain lining inflammation and sepsis, causing long-term disabilities and even fatalities. The disease spreads through close contact, such as sharing drinks or living in communal settings, making it crucial for young people to be vaccinated.

In response to the urgent need for immunization, the National Pharmacy Association chair, Olivier Picard, emphasized the importance of addressing gaps in the national vaccination strategy. Recent outbreaks in Kent and other regions have exposed the significant impact of meningitis B on affected individuals.

Currently, one million young people in England are eligible for a one-time MenB vaccine, targeting those in the final year of sixth form and students under 25 heading to residential colleges or universities. Prof Shen Lim encourages eligible individuals to schedule appointments at local pharmacies for the 2-dose MenB vaccination, ensuring adequate protection against the disease.